
Ahead of its planned Initial Public Offering (IPO), Practo is reportedly in advanced talks to raise $100-$125 Million in fresh capital, according to news reports. The round, structured as equity and debt, may value the company at around $700 Million post money. A global private equity firm is expected to head the investment, alongside existing backers.
The company was previously assessing a listing this year but is now understood to be planning a 2027 debut, though nothing has been formally confirmed. The fresh capital is to be used for expansion and acquisitions.
Practo last raised $32 Million in 2020 from Tencent, Peak XV Partners, Z47 Partners and Sofina. Overall, it has secured nearly $230 Million from investors including Ru-Net, RSI Fund, Thrive Capital and Capital G.
Founded by Shashank ND and Abhinav Lal in 2008, Practo operates an online platform for booking doctor appointments, teleconsultations, medicine orders and diagnostic tests. It also provides software tools to doctors, clinics and hospitals for appointment scheduling and patient record management.
Reports suggest that the company runs 40 co-branded dermatology clinics across India. It has expanded outside India to the US and the UAE. After entering the UAE market last year, it also began a pilot in the US during the same period.
Practo currently has more than 2 Lakh doctors on its US platform and reports a gross merchandise value run rate of over $75 Million there.
In FY25, Practo reported operating EBITDA of ₹15 Crore on revenue of ₹234 Crore. This compares with an EBITDA loss of ₹17 Crore in FY24, when revenue stood at ₹240 Crore.
The company said it audited over 1,000 healthcare establishments in FY25 and processed more than 4 Crore clinical data points. It also reported a 180% year-on-year increase in its network, taking the total number of hospitals on its platform to more than 1.5 Lakh.
Read More: India Aims to Get ₹1.79 Lakh Crore from State-Run IPOs by 2030!
If completed, the round would add to Practo’s existing capital base ahead of its expected IPO in 2027. The company has not issued an official statement on the fundraising.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 24, 2026, 1:13 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
